About Genepharm
Genepharm is a company based in Pallini (Greece) founded in 1967 was acquired by MSPharma in April 2019. It operates as a Reseller / Distribution. Genepharm offers products and services including Conventional Solids and Oncological Solids.
- Headquarter Pallini, Greece
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genepharm S.A.
- Date of Incorporation 29 Jun, 2006
- Jurisdiction Kolkata, West Bengal, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genepharm
Genepharm offers a comprehensive portfolio of products and services, including Conventional Solids and Oncological Solids.
Conventional tablets and capsules are produced for various therapies.
Oncological tablets and capsules are manufactured for cancer treatment.
Funding Insights of Genepharm
Investors in Genepharm
Genepharm has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and MSPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Generic formulations are manufactured by MSPharma across multiple therapeutic categories.
|
Locked | Locked | Locked |
Investor details for Genepharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genepharm
Investment portfolio details for Genepharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genepharm
Detailed financials for Genepharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genepharm Comparisons
Peer comparison for Genepharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genepharm
Detailed competitors of Genepharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genepharm
Complete news archive for Genepharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genepharm
Genepharm was founded in 1967 and raised its 1st funding round 40 years after it was founded.
Genepharm is headquartered in Pallini, Greece. It is registered at Pallini, Attica, Greece.
Genepharm is involved in the development and manufacturing of pharmaceutical products, focusing on conventional and oncological solids. Operations are conducted in a state-of-the-art facility in Pallini, Greece, adhering to European specifications. The company serves both domestic and international markets, with a presence in over 90 countries through strategic alliances with leading pharmaceutical firms. Therapeutic areas covered include cardiology, oncology, neurology, and more. Continuous investment in infrastructure and technology is prioritized to enhance product development and global reach.
Genepharm offers Conventional Solids and Oncological Solids.